Oxygenta Pharma — 360° view

Oxygenta Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹33 crore and a net loss of ₹2.74 crore for the September 2026 quarter.

Oxygenta Pharma (BSE: OXYGENTAPH) closed at ₹50.00 on 20 Nov 2026, down 15.4% over the past year. Its market capitalisation is ₹185 crore.

Share price
₹50.00 (20 Nov 2026)
Market cap
₹185 Cr (20 Nov 2026)
Revenue
₹33 Cr (September 2026 quarter)
Net profit
₹-3 Cr (September 2026 quarter)
ROCE
-33.6% (FY26)
ROE
% (FY26)
Book value
₹-12.7 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹71.59 / ₹43.00 (20 Nov 2026)
1-year return
-15.4% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: OXYGENTAPH

Incorporated in 1990, Oxygenta Pharmaceutical Ltd manufactures Bulk Drugs and API including Pharmaceutical preparation, and Organic Fine Chemicals.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.